White matter magnetic resonance imaging hyperintensity in Alzheimer's disease: correlations with corpus callosum

P Vermersch1, J Roche, M Hamon

  • 1Department of Neurology, CHU de Lille, France.

Journal of Neurology
|March 1, 1996
PubMed

Insights

Alzheimer's disease (AD) patients show more white matter lesions and corpus callosum atrophy than controls. These changes correlate with disease diagnosis and age, not disease severity.

Area of Science:

  • Neuroimaging
  • Neurology
  • Gerontology

Background:

  • Late-onset Alzheimer's disease (AD) is associated with white matter involvement.
  • Corpus callosum atrophy has been observed in AD, prompting further investigation.

Purpose of the Study:

  • To investigate correlations between corpus callosum atrophy, white matter hyperintensity (WMH), and disease severity in Alzheimer's disease.
  • To compare MRI findings of corpus callosum and white matter lesions between AD patients and controls.

Main Methods:

  • Magnetic Resonance Imaging (MRI) was used to compare 15 AD patients and 15 controls.
  • White matter lesions were scored using the Scheltens' rating scale.

Main Results:

  • AD patients exhibited significantly reduced corpus callosum area and more severe white matter lesions compared to controls.
  • Corpus callosum atrophy and lesion severity were primarily linked to Alzheimer's type dementia diagnosis and age.
  • A negative correlation was found between white matter lesion scores and corpus callosum area in AD patients.

Conclusions:

  • White matter lesions, including WMH and corpus callosum atrophy, are more prevalent in AD patients.
  • The increased white matter lesions in senile AD may result from combined aging and disease processes.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...